Briones David S. 4
4 · Hoth Therapeutics, Inc. · Filed Mar 7, 2019
Insider Transaction Report
Form 4
Briones David S.
Chief Financial Officer
Transactions
- Other
Options
2019-03-06+50,000→ 50,000 totalExercise: $5.88From: 2019-03-06Exp: 2024-03-06→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.